# Citocoline for Treatment in Fragile X-associated Tremor/Ataxia Syndrome

> **NCT02197104** · PHASE2 · COMPLETED · sponsor: **Rush University Medical Center** · enrollment: 10 (actual)

## Conditions studied

- Fragile X Tremor/Ataxia Syndrome

## Interventions

- **DRUG:** citocoline

## Key facts

- **NCT ID:** NCT02197104
- **Lead sponsor:** Rush University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02197104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02197104, "Citocoline for Treatment in Fragile X-associated Tremor/Ataxia Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02197104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*